Search Results - "Otero, Marisol E."

Real-world Data Reveal Long Drug Survival for Guselkumab in Patients with Plaque Psoriasis by Van Muijen, Marloes E., Thomas, Sarah E., Vellinga, Douwe, Bouwman, Silke, Van Doorn, Martijn B.A., Politiek, Klaziena, Otero, Marisol E., Van den Reek, Juul M.P.A., De Jong, Elke M.G.J.

“…Abstract is missing (Short communication)…”
Get full text

Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study by Atalay, S, Reek, J, Otero, M, Njoo, M, Mommers, J, Ossenkoppele, P, Koetsier, M, Berends, M, Kerkhof, P, Groenewoud, H, Broeder, A, Jong, E, Kievit, W

“…A dose reduction strategy for adalimumab, etanercept and ustekinumab in patients with psoriasis who have stable and low disease activity has recently been…”
Get full text

Beliefs About Medicines in Patients with Psoriasis Treated with Methotrexate or Biologics: A Cross-sectional Survey Study by Otero, Marisol E, van den Reek, Juul M P A, van de Kerkhof, Peter C M, Mertens, Jorre S, Seyger, Marieke M B, Kievit, Wietske, de Jong, Elke M G J

“…Methotrexate (MTX) and biologics are frequently used treatments for psoriasis. Exploring patients' beliefs about their treatment may help to elucidate…”
Get full text

Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis: A Randomized Clinical Trial by Atalay, Selma, van den Reek, Juul M P A, den Broeder, Alfons A, van Vugt, Lieke J, Otero, Marisol E, Njoo, Marcellus D, Mommers, Johannes M, Ossenkoppele, Paul M, Koetsier, Marjolein I, Berends, Maartje A, van de Kerkhof, Peter C M, Groenewoud, Hans M M, Kievit, Wietske, de Jong, Elke M G J

“…Biologics revolutionized the treatment of psoriasis. Biologics are given in a fixed dose, but lower doses might be possible. To investigate whether dose…”
Get more information

Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab by Schoot, Lara S., Atalay, Selma, Otero, Marisol E., Kievit, Wietske, Reek, Juul M.P.A., Jong, Elke M.G.J.

Get full text

Revealing patient characteristics and treatment outcomes among ultra-long users of biologics for psoriasis by Henckens, Nikki F T, Otero, Marisol E, van den Reek, Juul M PA, de Jong, Elke M GJ, Keijsers, Romy RMC, van Lümig, Paula PM, Ossenkoppele, Paul M, Haeck, Inge M, Hendricksen-Roelofzen, Judith HJ, Körver, John EM, Dodemont, Sharon RP, Velstra, Berit, Homan, Femke M, Berends, Maartje AM, Lindhout, Robert Jan, Oostveen, Annet M, Peters, Bas, Mommers, Johannes M, van Doorn, Martijn BA, Tjioe, Milan, Arnold, W Peter, Kuijpers, Astrid LA, Kleinpenning, Marloes M

Get full text

Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment by Thomas, Sarah E., Seyger, Marieke M. B., Mangnus, Josje E., Otero, Marisol E., Gostynski, Antoni H., Njoo, Marcellus D., Ossenkoppele, Paul M., Haeck, Inge M., Hendricksen-Roelofzen, Judith H. J., Körver, John E. M., Dodemont, Sharon R. P., Tupker, Ron A., Berends, Maartje A. M., Weppner-Parren, Lizelotte M. J. T., Keijsers, Romy R. M. C., Oostveen, Annet M., Peters, Bas, Mommers, Roland, van Doorn, Martijn B. A., Tjioe, Milan, Veldkamp, Wendelien R., Kuijpers, Astrid L. A., Kleinpenning, Marloes M., de Jong, Elke M. G. J., van den Reek, Juul M. P. A.

“…First-year Psoriasis Area and Severity Index (PASI) scores of patients with and without previous ustekinumab treatment were calculated. [...]after confounder…”
Get full text

Effectiveness of Biologic and Conventional Systemic Therapies in Adults with Chronic Plaque Psoriasis in Daily Practice: A Systematic Review by Zweegers, Jeffrey, Otero, Marisol E, van den Reek, Juul M P A, van Lümig, Paula P, Driessen, Rieke J, Kievit, Wietske, Seyger, Marieke M B, van de Kerkhof, Peter C M, de Jong, Elke M G J

“…The efficacy of biologic or conventional systemic therapies for psoriasis has been shown in randomized controlled trials. Effectiveness, however, has been…”
Get full text

Tailored Therapist-Guided Internet-Based Cognitive Behavioral Treatment for Psoriasis: A Randomized Controlled Trial by van Beugen, Sylvia, Ferwerda, Maaike, Spillekom-van Koulil, Saskia, Smit, Jurgen V, Zeeuwen-Franssen, Manon E J, Kroft, Elisabeth B M, de Jong, Elke M G J, Otero, Marisol E, Donders, A Rogier T, van de Kerkhof, Peter C M, van Middendorp, Henriët, Evers, Andrea W M

“…Patients with somatic conditions, such as psoriasis, frequently suffer from high burden of their disease in daily life and might benefit from internet-based…”
Get more information

Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial by Atalay, Selma, van den Reek, Juul M P A, van Vugt, Lieke J, Otero, Marisol E, van de Kerkhof, Peter C M, den Broeder, Alfons A, Kievit, Wietske, de Jong, Elke M G J

“…Psoriasis is an immune-mediated chronic inflammatory skin disorder for which several targeted biologic therapies became available in the last 10 years. Data…”
Get full text

Effectiveness of a Multidisciplinary Itch-coping Training Programme in Adults with Atopic Dermatitis by EVERS, Andrea W. M, DULLER, Piet, DE JONG, Elke M. G. J, OTERO, Marisol E, VERHAAK, Christianne M, VAN DER VALK, Pieter G. M, VAN DE KERKHOF, Peter C. M, KRAAIMAAT, Floris W

“…The short- and longer-term effectiveness of a brief, multidisciplinary itch-coping group training scheme in adults with atopic dermatitis was evaluated…”
Get full text

Development and design of a multidisciplinary training program for outpatient children and adolescents with psoriasis and their parents by Oostveen, Annet M., Spillekom-van Koulil, Saskia, Otero, Marisol E, Klompmaker, Wilma, Evers, Andrea W.M., Seyger, Marieke M.B.

“…Abstract Introduction: To describe and illustrate in a case-study design the development and design of a multidisciplinary training program for outpatient…”
Get full text

Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: An immunohistochemical study by van der Velden, Haike M. J., Pasch, Marcel C., van Erp, Piet E. J., van Lingen, Rosanne G., Otero, Marisol E., de Boer-van Huizen, Roelie T., van de Kerkhof, Peter C. M.

“…The combination of calcipotriol (Cp) and topical corticosteroids increases efficacy and reduces side effects as compared to monotherapies. Previous studies…”
Get full text

Professionals' Shared Competences in Multidisciplinary Dementia Care: Validation of a Self-Appraisal Instrument by Otero, Marisol E., Drasković, Irena, Bottema, Ben, Lucassen, Peter L., Degen, Saskia, Olde Rikkert, Marcel G. M., Vernooij-Dassen, Myrra J. M.

Get full text

Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin by Smit, Jürgen V, de Jong, Elke M.G.J, van Hooijdonk, Candida A.E.M, Otero, Marisol E, Boezeman, Jan B.M, van de Kerkhof, Peter C.M

“…Bexarotene, a novel synthetic retinoid X receptor (RXR)–selective retinoid, has been reported to have antiproliferative and apoptotic stimulating effects in…”
Get full text

Revealing patient characteristics and treatment outcomes in ultra-long biologic users for psoriasis by Henckens, Nikki F T, Otero, Marisol E, van den Reek, Juul M P A, de Jong, Elke M G J, Keijsers, Romy R M C

“…Biologics are effective for psoriasis, but little is known regarding patients treated with one biologic for an "ultra-long" duration. To explore the…”
Get full text

Gram-positive anaerobe cocci (GPAC) are underrepresented in the microbiome of filaggrin-deficient human skin by Zeeuwen, Patrick L.J.M., PhD, Ederveen, Thomas H.A., MSc, van der Krieken, Danique A., MSc, Niehues, Hanna, MSc, Boekhorst, Jos, PhD, Kezic, Sanja, PhD, Hanssen, Daniëlle A.T., MSc, Otero, Marisol E., MSc, van Vlijmen-Willems, Ivonne M.J.J., BSc, Rodijk-Olthuis, Diana, BSc, Falcone, Denise, MSc, van den Bogaard, Ellen H.J., PhD, Kamsteeg, Marijke, PhD, MD, de Koning, Heleen D., PhD, MD, Zeeuwen-Franssen, Manon E.J., PhD, MD, van Steensel, Maurice A.M., PhD, MD, Kleerebezem, Michiel, PhD, Timmerman, Harro M., PhD, van Hijum, Sacha A.F.T., PhD, Schalkwijk, Joost, PhD

“…Mutations in the filaggrin gene, which cause the skin disease ichthyosis vulgaris and are a genetic risk factor for atopic dermatitis, alter the cutaneous…”
Get full text

Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort by Van Muijen, Marloes E, Thomas, Sarah E, Groenewoud, Hans M M, Otero, Marisol E, Ossenkoppele, Paul M, Njoo, Marcellus D, Dodemont, Sharon R P, Kop, Else N, Berends, Maartje A M, Koetsier, Marjolein I A, Mommers, Johannes M, Körver, John E M, Tupker, Ron A, De Bruin-Weller, Marjolein S, Weppner-Parren, Lizelotte J M T, Peters, Bas, Kleinpenning, Marloes M, Kuijpers, Astrid L A, Arnold, W Peter, Van Lümig, Paula P M, Van den Reek, Juul M P A, De Jong, Elke M G J

“…Real-world evidence, directly comparing the effectiveness of interleukin (IL)17-inhibitors, IL23-inhibitors, tumour necrosis factor alpha (TNF-α)-inhibitors…”
Get full text

Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry by van Hal, Tamara W, van den Reek, Juul M P A, Wenink, Mark H, Otero, Marisol E, Ossenkoppele, Paul M, Njoo, Marcellus D, Oostveen, Annet, Peters, Bas, Tjioe, Milan, Kop, Else N, Körver, John E M, Dodemont, Sharon R P, Kleinpenning, Marloes M, Berends, Maartje A M, Veldkamp, Wendelien R, van Doorn, Martijn B A, Mommers, Johannes M, Lindhout, Robert-Jan, Kuijpers, Astrid L A, van Lümig, Paula P, de Jonge, C Els J, Tupker, Ron A, Hendricksen, Judith, Keijsers, Romy R, van den Hoogen, Frank H J, Vriezekolk, Johanna E, de Jong, Elke M G J

“…Little is known about the extent of impairments in work and activities of daily life (ADL) in patients with psoriasis, and the influence of contextual factors…”
Get full text

Gram-positive anaerobe cocci are underrepresented in the microbiome of filaggrin-deficient human skin : Letter to the editor by Zeeuwen, Patrick L.J.M, Ederveen, Thomas H.A, Krieken, Danique A., van der, Niehues, Hanna, Boekhorst, Jos, Kezic, Sanja, Hanssen, Daniëlle A.T, Otero, Marisol E, Rodijk-Olthuis, Diana, Falcone, Denise, Bogaard, Ellen H.J., van den, Kamsteeg, Marijke, Koning, Heleen D., de, Zeeuwen-Franssen, Manon E.J, Steensel, Maurice A.M., van, Kleerebezem, Michiel, Timmerman, Harro M, Hijum, Sacha A.F.T., van, Schalkwijk, Joost

Get full text